LK
General Information
DCTPep ID DCTPep06064
Peptide Name LK
Sequence LKKLLKLLKKLLKL
Sequence Length 14
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
ACP Tumor active peptide Cancer targeted peptides Membrane-targeted
Activity Information
Cell Line | Disease | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|
HeLa | Human papillomavirus-related endocervical adenocarcinoma | 20% Survival=20μM | MTT assay | 24h | Patent |
Hemolytic Activity Mouse red blood cells:Hemolysis rate=48%=50μM
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Structure Information
PDB ID Not available
Predicted Structure Not available
(Please note that there is the predicted structure, predicted by AlphaFold)
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C84H162N20O15
Absent amino acids ACDEFGHIMNPQRSTVWY
Theoretical pI 10.70
Acidic residues 0
Basic residues 6
Polar residues 0
Molecular weight (Average) 1692.34
Molecular weight (Monoisotopic) 1691.25
Common amino acids L
Net charge 6
Instability index (II) -39.23
Aliphatic index 222.86
Grand average of hydropathicity (GRAVY) 0.500
Half Life
5.5 hours (mammalian reticulocytes, in vitro).
3 min (yeast, in vivo).
2 min (Escherichia coli, in vivo).
Extinction coefficients
Should not be visible by UV spectrophotometry.
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID CN110862458A
Patent Title Combined peptide with acid-activated anti-tumor activity and clinical application of combined peptide
Other Iinformation Not available
Other Published ID Not available